Research, partnerships and case studies
![](https://cdn.prod.website-files.com/642a7d54b3cd4e155c5e65de/668512d52380e376d2fcf16b_Getty_91559994_CircularDNA_edited.jpg)
![](https://cdn.prod.website-files.com/642a7d54b3cd4e155c5e65de/65f040e8caf9bd3a5595c6ac_zoe-schaeffer-gHAAa9U4a0k-unsplash.webp)
![](https://cdn.prod.website-files.com/642a7d54b3cd4e155c5e65de/6660698d739bddacbc55cbf2_blog%20post%20preprint%20cover.webp)
![](https://cdn.prod.website-files.com/642a7d54b3cd4e155c5e65de/66586787abb60fbecb2e299b_Salmonella-CDC-c7cad348d7dd6b7c5d2c6344eaef2ce0-edit.png)
![](https://cdn.prod.website-files.com/642a7d54b3cd4e155c5e65de/664c5a02aabc86e4e484a36d_candida-auris-illustration-x.webp)
![](https://cdn.prod.website-files.com/642a7d54b3cd4e155c5e65de/65f0416a282385adfb38cc8a_65ccb0f9b3bb8e1d5c78e195_cslogo.webp)
Solu to Enable a Cedars-Sinai Medical Center Research Study on Epidemiological and Antibiotic Resistance of Hospital Infections with Genomics
Cedars-Sinai Medical Center and health technology company Solu announce today a partnership to study and understand hospital-acquired infections from an epidemiological and antibiotic resistance perspective. Solu offers an end-to-end service that provides insight into the causes of antibiotic resistance and whether the infection is hospital-acquired.
![](https://cdn.prod.website-files.com/642a7d54b3cd4e155c5e65de/65d743378cdd1ef56e122c2a_f0181250-800px-wm.jpg)
![](https://cdn.prod.website-files.com/642a7d54b3cd4e155c5e65de/65d46e5db170aea0af3ee3cb_pexels-pixabay-64231.jpg)
![](https://cdn.prod.website-files.com/642a7d54b3cd4e155c5e65de/65f03fc04ab17bb2a8d2ff80_AdobeStock_605905285.webp)
Analyzing Candida genomes with candida.app & Solu
The emerging fungal pathogen Candida auris is a growing public health threat due to its fast spread, multidrug-resistance, high transmissibility, and high mortality rates. We created a free web application called candida.app for fast and easy genomic characterization of C.auris isolates.
![](https://cdn.prod.website-files.com/642a7d54b3cd4e155c5e65de/65cce2fdef2884b723534f7a_photo-1582560475093-ba66accbc424.jpeg)
Investigating a Salmonella Typhi outbreak with Solu Platform
Salmonella Typhi is a bacterial pathogen that causes typhoid fever, a serious illness affecting millions of people worldwide. In this case study, we will explore the use of the Solu platform to investigate a Salmonella Typhi outbreak and analyze the genomic data associated with it.
![](https://cdn.prod.website-files.com/642a7d54b3cd4e155c5e65de/65ccde5f20ff8b200cfca092_screenshot.png)
Validating the results of candida.app and Solu Platform
Candida auris is an emerging health threat, and better genomic analysis tool are needed for its surveillance. Candida.app is a free, user-friendly tool for genomic analysis of C. auris isolates. This validation study shows that Solu and candida.app are accurate for genomıc characterization of Candida auris.